您的购物车当前为空
别名 3',5-Dichlorosalicylanilide
SARS-CoV-2-IN-14 是一种有效的、可口服的 SARS-CoV-2 抑制剂(IC50 :0.39 μM),是一种氯硝柳胺类似物。SARS-CoV-2-IN-14在人血浆和肝 S9 酶测定中比氯硝柳胺稳定性更强。SARS-CoV-2-IN-14以口服的方式给药可以提高其生物利用度和半衰期。


为众多的药物研发团队赋能,
让新药发现更简单!
SARS-CoV-2-IN-14 是一种有效的、可口服的 SARS-CoV-2 抑制剂(IC50 :0.39 μM),是一种氯硝柳胺类似物。SARS-CoV-2-IN-14在人血浆和肝 S9 酶测定中比氯硝柳胺稳定性更强。SARS-CoV-2-IN-14以口服的方式给药可以提高其生物利用度和半衰期。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 108 | In stock | |
| 5 mg | ¥ 221 | In stock | |
| 10 mg | ¥ 359 | In stock | |
| 25 mg | ¥ 648 | In stock | |
| 50 mg | ¥ 978 | In stock | |
| 100 mg | ¥ 1,450 | In stock | |
| 200 mg | ¥ 2,150 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 226 | In stock |
SARS-CoV-2-IN-14 相关产品
| 产品描述 | SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide. SARS-CoV-2-IN-14 was more stable than niclosamide in the determination of human plasma and liver S9 enzyme. Oral administration of SARS-CoV-2-IN-14 can improve its bioavailability and half-life. |
| 靶点活性 | SARS-CoV-2:0.39 μM |
| 别名 | 3',5-Dichlorosalicylanilide |
| 分子量 | 282.12 |
| 分子式 | C13H9Cl2NO2 |
| CAS No. | 22203-98-1 |
| Smiles | C(NC1=CC(Cl)=CC=C1)(=O)C2=C(O)C=CC(Cl)=C2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 9 mg/mL (31.9 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容